From Philadelphia, at a meeting of the American Society of Tropical Medicine and Hygiene
An orally delivered drug for treatment of sleeping sickness is demonstrating considerable effectiveness in its first large-scale test in Africa.
Researchers used blood tests obtained at clinics in the Democratic Republic of the Congo, Angola, and Sudan to identify 273 people who had the West African version of sleeping sickness.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.